Please assess the completion status of the following clinical trial:

Trial Title: A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males and females aged 18 years to less than 55 years~* Body weight 50kg or greater~* Body mass index (BMI) between 18 and 42.0 kg/m2~Exclusion Criteria:~* Evidence of a clinically significant medical condition, disorder or disease~* Evidence of hepatobiliary disease~* Any clinically relevant abnormal laboratory test result~* Evidence or history of alcohol or substance abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- CSL112 (Type: EXPERIMENTAL): Multiple ascending intravenous doses of CSL112
- Placebo (Type: PLACEBO_COMPARATOR): Multiple intravenous infusions of placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).